twoXAR
Yunsheng (Tony) Hsieh currently serves as DMPK Head at Aria Pharmaceuticals since June 2021 and has been a CSO/Consultant at Novotech since 2012. Previous experience includes positions as Sr. Director of DMPK/Bioanalytical at HD Biosciences in 2011, Director of Bioanalytical/DMPK at BioDuro in 2011, Sr. Principal Scientist at Merck from 2009 to 2010, and Sr. Principal Scientist at Schering-Plough Research Institute from 1998 to 2009. Yunsheng Hsieh holds a Postdoc in Pharmaceutical Sciences from the University of California, San Francisco, a Postdoc in Pharmacology from the University of Florida, and a Ph.D. in Chemistry from Michigan State University. Additionally, education was completed at Tsinghua University.
This person is not in any teams
This person is not in any offices
twoXAR
twoXAR is a pharmaceutical company that has built a development portfolio targeting more than 18 different diseases. twoXAR’s unique approach to drug discovery combines steps from the traditional multi-step approach to R&D that severely limits the pace...